Industry News
Clinical trials centre adopts unified data management platform
The NHMRC Clinical Trial Centre will use technology company Medidata's unified platform and analytics for all major new studies starting in 2018. [ + ]
How much does cancer cost the Australian economy?
Experiencing cancer is tough for any patient, as well as their family and friends. But it seems that cancer is also not great for the Australian economy. [ + ]
Chris Goodnow appointed as executive director of Garvan
The Garvan Institute of Medical Research has appointed Professor Chris Goodnow as its executive director. [ + ]
Artificial enzymes use light to kill bacteria
Made from tiny nanorods, the newly developed 'NanoZymes' use visible light to create highly reactive oxygen species that rapidly break down and kill bacteria. [ + ]
Optimum treatment for advanced melanoma patients revealed
Researchers now have greater clarity on the best course of treatment for patients with advanced melanoma which has spread to the brain. [ + ]
Want to help trial a vaccine for coeliac disease?
The University of the Sunshine Coast's Clinical Trials Centre has launched a clinical trial of a new vaccine that aims to switch off the immune response to gluten. [ + ]
Medical cannabis conference coming to Sydney
CannaTech AU will highlight industry thought leaders from Australia and around the world who are known for their contributions to the global medical cannabis market. [ + ]
New anticancer protein found to suppress liver tumours
A newly discovered anticancer protein has been found to prevent the uncontrolled proliferation of cancer cells in the liver. [ + ]
Why are rheumatoid arthritis patients at risk of heart disease?
Treating rheumatoid arthritis patients with a high-density lipoprotein (HDL) may limit their risk of developing heart disease, according to Melbourne researchers. [ + ]
The gene mutation that wards off malaria
Researchers have shed light on how humans who live in close quarters with malaria-carrying mosquitoes may evolve defences against the disease. [ + ]
Drug hoped to treat CFS causes impaired immune function — study
Reports that a drug used to treat autoimmune diseases and cancer could also treat CFS have been refuted by a new Griffith University study. [ + ]
Regenerative medicine through the lens of an artist
In 2017 the AMRI ran its first Artist in Residence program, inviting nine artists to each spend a week exploring the theme of regeneration. [ + ]
Alliance Agreement to advance laser-based cancer treatment
The Hudson Institute and Invion have signed a Research & Development Alliance Agreement in order to advance the latter's cancer treatment technology, Photosoft. [ + ]
Join the March for Science on 14 April
The second global March for Science is taking place on Saturday, 14 April, and Australian science enthusiasts are encouraged to take part. [ + ]
Less invasive glaucoma treatment gets approval
A surgical treatment for glaucoma that involves implantation of a microfistula tube has been approved for general use in Australia. [ + ]
